Press Room

Press Release


JRS Pharma’s "PROSOLV® EASYtab" - exciting All-in-One, High Functionality, Excipient Composite


JRS Pharma to introduce its newest product derived from PROSOLV® Technology

JRS Pharma is proud to introduce its newest product derived from the PROSOLV® Technology Platform, PROSOLV® ODT

JRS Pharma will launch its new Orally Disintegrating Tablet matrix technology - PROSOLV® ODT in 2010.  PROSOLV ODT is a unique combination of Microcrystalline Cellulose, Colloidal Silicon Dioxide, Mannitol, Fructose and Crospovidone and manufactured by using JRS Pharma’s unique co-processing technology.

PROSOLV® ODT addresses formulation and manufacturing challenges with robust functional performance required for high speed tablet manufacture. Patients experience a tablet with pleasing mouth feel and fast disintegration, in the mouth, without the need of water. With no licensing and royalty agreements required, JRS PHARMA makes PROSOLV® ODT ready to use for scientists, manufacturing, and business professionals alike.

Back to Main Press Release Listing